Global Diagnostic Nuclear Medicines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Diagnostic Nuclear Medicines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Diagnostic Nuclear Medicines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Diagnostic Nuclear Medicines by Country/Region, 2017, 2022 & 2028

2.2 Diagnostic Nuclear Medicines Segment by Type

2.2.1 Tc-99m

2.2.2 F-18

2.2.3 Other

2.3 Diagnostic Nuclear Medicines Sales by Type

2.3.1 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

2.3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Diagnostic Nuclear Medicines Sale Price by Type (2017-2022)

2.4 Diagnostic Nuclear Medicines Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Diagnostic Nuclear Medicines Sales by Application

2.5.1 Global Diagnostic Nuclear Medicines Sale Market Share by Application (2017-2022)

2.5.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Diagnostic Nuclear Medicines Sale Price by Application (2017-2022)

3 Global Diagnostic Nuclear Medicines by Company

3.1 Global Diagnostic Nuclear Medicines Breakdown Data by Company

3.1.1 Global Diagnostic Nuclear Medicines Annual Sales by Company (2020-2022)

3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Company (2020-2022)

3.2 Global Diagnostic Nuclear Medicines Annual Revenue by Company (2020-2022)

3.2.1 Global Diagnostic Nuclear Medicines Revenue by Company (2020-2022)

3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Company (2020-2022)

3.3 Global Diagnostic Nuclear Medicines Sale Price by Company

3.4 Key Manufacturers Diagnostic Nuclear Medicines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Diagnostic Nuclear Medicines Product Location Distribution

3.4.2 Players Diagnostic Nuclear Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Diagnostic Nuclear Medicines by Geographic Region

4.1 World Historic Diagnostic Nuclear Medicines Market Size by Geographic Region (2017-2022)

4.1.1 Global Diagnostic Nuclear Medicines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Diagnostic Nuclear Medicines Annual Revenue by Geographic Region

4.2 World Historic Diagnostic Nuclear Medicines Market Size by Country/Region (2017-2022)

4.2.1 Global Diagnostic Nuclear Medicines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Diagnostic Nuclear Medicines Annual Revenue by Country/Region

4.3 Americas Diagnostic Nuclear Medicines Sales Growth

4.4 APAC Diagnostic Nuclear Medicines Sales Growth

4.5 Europe Diagnostic Nuclear Medicines Sales Growth

4.6 Middle East & Africa Diagnostic Nuclear Medicines Sales Growth

5 Americas

5.1 Americas Diagnostic Nuclear Medicines Sales by Country

5.1.1 Americas Diagnostic Nuclear Medicines Sales by Country (2017-2022)

5.1.2 Americas Diagnostic Nuclear Medicines Revenue by Country (2017-2022)

5.2 Americas Diagnostic Nuclear Medicines Sales by Type

5.3 Americas Diagnostic Nuclear Medicines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Diagnostic Nuclear Medicines Sales by Region

6.1.1 APAC Diagnostic Nuclear Medicines Sales by Region (2017-2022)

6.1.2 APAC Diagnostic Nuclear Medicines Revenue by Region (2017-2022)

6.2 APAC Diagnostic Nuclear Medicines Sales by Type

6.3 APAC Diagnostic Nuclear Medicines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Diagnostic Nuclear Medicines by Country

7.1.1 Europe Diagnostic Nuclear Medicines Sales by Country (2017-2022)

7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2022)

7.2 Europe Diagnostic Nuclear Medicines Sales by Type

7.3 Europe Diagnostic Nuclear Medicines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Diagnostic Nuclear Medicines by Country

8.1.1 Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2017-2022)

8.2 Middle East & Africa Diagnostic Nuclear Medicines Sales by Type

8.3 Middle East & Africa Diagnostic Nuclear Medicines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Diagnostic Nuclear Medicines

10.3 Manufacturing Process Analysis of Diagnostic Nuclear Medicines

10.4 Industry Chain Structure of Diagnostic Nuclear Medicines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Diagnostic Nuclear Medicines Distributors

11.3 Diagnostic Nuclear Medicines Customer

12 World Forecast Review for Diagnostic Nuclear Medicines by Geographic Region

12.1 Global Diagnostic Nuclear Medicines Market Size Forecast by Region

12.1.1 Global Diagnostic Nuclear Medicines Forecast by Region (2023-2028)

12.1.2 Global Diagnostic Nuclear Medicines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Diagnostic Nuclear Medicines Forecast by Type

12.7 Global Diagnostic Nuclear Medicines Forecast by Application

13 Key Players Analysis

13.1 Bracco Imaging

13.1.1 Bracco Imaging Company Information

13.1.2 Bracco Imaging Diagnostic Nuclear Medicines Product Offered

13.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bracco Imaging Main Business Overview

13.1.5 Bracco Imaging Latest Developments

13.2 Bayer

13.2.1 Bayer Company Information

13.2.2 Bayer Diagnostic Nuclear Medicines Product Offered

13.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer Main Business Overview

13.2.5 Bayer Latest Developments

13.3 Curium Pharmaceuticals

13.3.1 Curium Pharmaceuticals Company Information

13.3.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Offered

13.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Curium Pharmaceuticals Main Business Overview

13.3.5 Curium Pharmaceuticals Latest Developments

13.4 Nordion

13.4.1 Nordion Company Information

13.4.2 Nordion Diagnostic Nuclear Medicines Product Offered

13.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Nordion Main Business Overview

13.4.5 Nordion Latest Developments

13.5 Triad Isotopes

13.5.1 Triad Isotopes Company Information

13.5.2 Triad Isotopes Diagnostic Nuclear Medicines Product Offered

13.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Triad Isotopes Main Business Overview

13.5.5 Triad Isotopes Latest Developments

13.6 Lantheus

13.6.1 Lantheus Company Information

13.6.2 Lantheus Diagnostic Nuclear Medicines Product Offered

13.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Lantheus Main Business Overview

13.6.5 Lantheus Latest Developments

13.7 GE Healthcare

13.7.1 GE Healthcare Company Information

13.7.2 GE Healthcare Diagnostic Nuclear Medicines Product Offered

13.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GE Healthcare Main Business Overview

13.7.5 GE Healthcare Latest Developments

13.8 China Isotope & Radiation

13.8.1 China Isotope & Radiation Company Information

13.8.2 China Isotope & Radiation Diagnostic Nuclear Medicines Product Offered

13.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 China Isotope & Radiation Main Business Overview

13.8.5 China Isotope & Radiation Latest Developments

13.9 Jubilant Pharma

13.9.1 Jubilant Pharma Company Information

13.9.2 Jubilant Pharma Diagnostic Nuclear Medicines Product Offered

13.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jubilant Pharma Main Business Overview

13.9.5 Jubilant Pharma Latest Developments

13.10 Eli Lilly

13.10.1 Eli Lilly Company Information

13.10.2 Eli Lilly Diagnostic Nuclear Medicines Product Offered

13.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Eli Lilly Main Business Overview

13.10.5 Eli Lilly Latest Developments

13.11 Novartis

13.11.1 Novartis Company Information

13.11.2 Novartis Diagnostic Nuclear Medicines Product Offered

13.11.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Novartis Main Business Overview

13.11.5 Novartis Latest Developments

13.12 SIEMENS

13.12.1 SIEMENS Company Information

13.12.2 SIEMENS Diagnostic Nuclear Medicines Product Offered

13.12.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 SIEMENS Main Business Overview

13.12.5 SIEMENS Latest Developments

13.13 Dongcheng

13.13.1 Dongcheng Company Information

13.13.2 Dongcheng Diagnostic Nuclear Medicines Product Offered

13.13.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Dongcheng Main Business Overview

13.13.5 Dongcheng Latest Developments

13.14 Navidea

13.14.1 Navidea Company Information

13.14.2 Navidea Diagnostic Nuclear Medicines Product Offered

13.14.3 Navidea Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Navidea Main Business Overview

13.14.5 Navidea Latest Developments

14 Research Findings and Conclusion

Table 1. Diagnostic Nuclear Medicines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Diagnostic Nuclear Medicines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tc-99m

Table 4. Major Players of F-18

Table 5. Major Players of Other

Table 6. Global Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 7. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 8. Global Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2022)

Table 10. Global Diagnostic Nuclear Medicines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 12. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 13. Global Diagnostic Nuclear Medicines Revenue by Application (2017-2022)

Table 14. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2022)

Table 15. Global Diagnostic Nuclear Medicines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Diagnostic Nuclear Medicines Sales by Company (2020-2022) & (K Units)

Table 17. Global Diagnostic Nuclear Medicines Sales Market Share by Company (2020-2022)

Table 18. Global Diagnostic Nuclear Medicines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Diagnostic Nuclear Medicines Revenue Market Share by Company (2020-2022)

Table 20. Global Diagnostic Nuclear Medicines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Diagnostic Nuclear Medicines Producing Area Distribution and Sales Area

Table 22. Players Diagnostic Nuclear Medicines Products Offered

Table 23. Diagnostic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Diagnostic Nuclear Medicines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Diagnostic Nuclear Medicines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Diagnostic Nuclear Medicines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Diagnostic Nuclear Medicines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Diagnostic Nuclear Medicines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Diagnostic Nuclear Medicines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Diagnostic Nuclear Medicines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Diagnostic Nuclear Medicines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 35. Americas Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 36. Americas Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 38. Americas Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 39. Americas Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 40. Americas Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 41. Americas Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 42. APAC Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)

Table 43. APAC Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2022)

Table 44. APAC Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Diagnostic Nuclear Medicines Revenue Market Share by Region (2017-2022)

Table 46. APAC Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 47. APAC Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 48. APAC Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 49. APAC Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 50. Europe Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 52. Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 54. Europe Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 56. Europe Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Diagnostic Nuclear Medicines

Table 67. Key Market Challenges & Risks of Diagnostic Nuclear Medicines

Table 68. Key Industry Trends of Diagnostic Nuclear Medicines

Table 69. Diagnostic Nuclear Medicines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Diagnostic Nuclear Medicines Distributors List

Table 72. Diagnostic Nuclear Medicines Customer List

Table 73. Global Diagnostic Nuclear Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Diagnostic Nuclear Medicines Sales Market Forecast by Region

Table 75. Global Diagnostic Nuclear Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Diagnostic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Diagnostic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Diagnostic Nuclear Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Diagnostic Nuclear Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Diagnostic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Diagnostic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Diagnostic Nuclear Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Diagnostic Nuclear Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Diagnostic Nuclear Medicines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Diagnostic Nuclear Medicines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Diagnostic Nuclear Medicines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Diagnostic Nuclear Medicines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Diagnostic Nuclear Medicines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Diagnostic Nuclear Medicines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Bracco Imaging Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 94. Bracco Imaging Diagnostic Nuclear Medicines Product Offered

Table 95. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Bracco Imaging Main Business

Table 97. Bracco Imaging Latest Developments

Table 98. Bayer Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 99. Bayer Diagnostic Nuclear Medicines Product Offered

Table 100. Bayer Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Bayer Main Business

Table 102. Bayer Latest Developments

Table 103. Curium Pharmaceuticals Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 104. Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Offered

Table 105. Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Curium Pharmaceuticals Main Business

Table 107. Curium Pharmaceuticals Latest Developments

Table 108. Nordion Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 109. Nordion Diagnostic Nuclear Medicines Product Offered

Table 110. Nordion Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Nordion Main Business

Table 112. Nordion Latest Developments

Table 113. Triad Isotopes Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 114. Triad Isotopes Diagnostic Nuclear Medicines Product Offered

Table 115. Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Triad Isotopes Main Business

Table 117. Triad Isotopes Latest Developments

Table 118. Lantheus Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 119. Lantheus Diagnostic Nuclear Medicines Product Offered

Table 120. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Lantheus Main Business

Table 122. Lantheus Latest Developments

Table 123. GE Healthcare Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 124. GE Healthcare Diagnostic Nuclear Medicines Product Offered

Table 125. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. GE Healthcare Main Business

Table 127. GE Healthcare Latest Developments

Table 128. China Isotope & Radiation Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 129. China Isotope & Radiation Diagnostic Nuclear Medicines Product Offered

Table 130. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. China Isotope & Radiation Main Business

Table 132. China Isotope & Radiation Latest Developments

Table 133. Jubilant Pharma Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 134. Jubilant Pharma Diagnostic Nuclear Medicines Product Offered

Table 135. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Jubilant Pharma Main Business

Table 137. Jubilant Pharma Latest Developments

Table 138. Eli Lilly Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 139. Eli Lilly Diagnostic Nuclear Medicines Product Offered

Table 140. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Eli Lilly Main Business

Table 142. Eli Lilly Latest Developments

Table 143. Novartis Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 144. Novartis Diagnostic Nuclear Medicines Product Offered

Table 145. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Novartis Main Business

Table 147. Novartis Latest Developments

Table 148. SIEMENS Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 149. SIEMENS Diagnostic Nuclear Medicines Product Offered

Table 150. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. SIEMENS Main Business

Table 152. SIEMENS Latest Developments

Table 153. Dongcheng Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 154. Dongcheng Diagnostic Nuclear Medicines Product Offered

Table 155. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Dongcheng Main Business

Table 157. Dongcheng Latest Developments

Table 158. Navidea Basic Information, Diagnostic Nuclear Medicines Manufacturing Base, Sales Area and Its Competitors

Table 159. Navidea Diagnostic Nuclear Medicines Product Offered

Table 160. Navidea Diagnostic Nuclear Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Navidea Main Business

Table 162. Navidea Latest Developments

List of Figures

Figure 1. Picture of Diagnostic Nuclear Medicines

Figure 2. Diagnostic Nuclear Medicines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Diagnostic Nuclear Medicines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Diagnostic Nuclear Medicines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Diagnostic Nuclear Medicines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tc-99m

Figure 10. Product Picture of F-18

Figure 11. Product Picture of Other

Figure 12. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2021

Figure 13. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2022)

Figure 14. Diagnostic Nuclear Medicines Consumed in Oncology

Figure 15. Global Diagnostic Nuclear Medicines Market: Oncology (2017-2022) & (K Units)

Figure 16. Diagnostic Nuclear Medicines Consumed in Cardiology

Figure 17. Global Diagnostic Nuclear Medicines Market: Cardiology (2017-2022) & (K Units)

Figure 18. Diagnostic Nuclear Medicines Consumed in Other

Figure 19. Global Diagnostic Nuclear Medicines Market: Other (2017-2022) & (K Units)

Figure 20. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2022)

Figure 21. Global Diagnostic Nuclear Medicines Revenue Market Share by Application in 2021

Figure 22. Diagnostic Nuclear Medicines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Diagnostic Nuclear Medicines Revenue Market Share by Company in 2021

Figure 24. Global Diagnostic Nuclear Medicines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Diagnostic Nuclear Medicines Revenue Market Share by Geographic Region in 2021

Figure 26. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2022)

Figure 27. Global Diagnostic Nuclear Medicines Revenue Market Share by Country/Region in 2021

Figure 28. Americas Diagnostic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 29. Americas Diagnostic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 30. APAC Diagnostic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 31. APAC Diagnostic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 32. Europe Diagnostic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 33. Europe Diagnostic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Diagnostic Nuclear Medicines Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Diagnostic Nuclear Medicines Revenue 2017-2022 ($ Millions)

Figure 36. Americas Diagnostic Nuclear Medicines Sales Market Share by Country in 2021

Figure 37. Americas Diagnostic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 38. United States Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Diagnostic Nuclear Medicines Sales Market Share by Region in 2021

Figure 43. APAC Diagnostic Nuclear Medicines Revenue Market Share by Regions in 2021

Figure 44. China Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Diagnostic Nuclear Medicines Sales Market Share by Country in 2021

Figure 51. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 52. Germany Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Country in 2021

Figure 59. Egypt Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Diagnostic Nuclear Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Diagnostic Nuclear Medicines in 2021

Figure 65. Manufacturing Process Analysis of Diagnostic Nuclear Medicines

Figure 66. Industry Chain Structure of Diagnostic Nuclear Medicines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles